The firm is a U.S.-based venture capital investor focused exclusively on women’s health, with investments spanning life sciences, digital health, and technology-enabled healthcare services. The firm primarily invests at the Seed and Series A stages, typically committing $1M–$3M per investment. The firm can lead or co-lead financing rounds and takes an active approach to portfolio development, often seeking board representation or observer rights. The firm primarily targets U.S.-based companies but also considers international opportunities when investment proceeds support U.S.-focused activities, including regulatory development, clinical validation, or commercialization.
The firm invests in healthcare solutions addressing conditions that exclusively or disproportionately affect women, as well as diseases where female-specific physiology creates opportunities to improve diagnosis, treatment, and clinical outcomes. The firm evaluates opportunities across therapeutics, medical devices, diagnostics, digital health, and technology-enabled healthcare delivery. Investment decisions are guided by four principal considerations: transformative innovation, access to care, affordability, and systemic improvement in healthcare delivery. The firm prioritizes technologies and business models capable of improving patient outcomes, reducing barriers to adoption, and addressing significant gaps in women’s healthcare.
From a company and management team perspective, the firm seeks differentiated healthcare solutions with strong commercial potential and a clear pathway to the U.S. market. The firm places particular emphasis on measurable patient impact, scalability, and the ability to improve healthcare accessibility and affordability. The firm takes an active role in supporting portfolio companies through strategic guidance, governance participation, business development, and commercialization planning.
If you are interested in more information about this investor and other investors tracked by LSN, please email salescore@lifesciencenation.com.
